Novavax Inc and partner Serum Institute of India say they have received emergency use authorisation for their Covid-19 vaccine in Indonesia, making it the first approval anywhere in the world for Novavax, reports Reuters.

For Indonesia, the shot will be manufactured by the world's largest vaccine manufacturer, Serum Institute, and sold under the Indian company's brand name, Covovax.

Novavax said initial shipments into Indonesia are expected to begin imminently.

The country is slated to receive 20 million doses of the protein-based vaccine this year, according to the government.